Federica F. O'Brien
CIK: 0001140119
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- May 19, 2026MGNX
MACROGENICS INC
Award(A)DirectStock Option (right to buy)
22K shares- - May 19, 2026MGNX
MACROGENICS INC
Award(A)DirectRestricted Stock Unit
3.8K shares- - May 18, 2026MGNX
MACROGENICS INC
Exercise(M)Direct3.8K shares- - May 28, 2025TELA
TELA Bio, Inc.
Award(A)Direct8K shares- - May 21, 2025MGNX
MACROGENICS INC
Award(A)DirectRestricted Stock Unit
3.8K shares- - May 21, 2025MGNX
MACROGENICS INC
Award(A)DirectStock Option (right to buy)
22K shares- - May 21, 2025MGNX
MACROGENICS INC
Award(A)DirectStock Option (right to buy)
65K shares at avg. $1.27- - May 20, 2025MGNX
MACROGENICS INC
Exercise(M)Direct6.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 |  MGNX MACROGENICS INC | Award(A) Stock Option (right to buy) | 22,000 | - | - | Direct |
| May 19, 2026 | MGNX MACROGENICS INC | Award(A) Restricted Stock Unit | 3,750 | - | - | Direct |
| May 18, 2026 | MGNX MACROGENICS INC | Exercise(M) | 3,750 | - | $0 | Direct |
| May 28, 2025 |  TELA TELA Bio, Inc. | Award(A) | 7,950 | - | - | Direct |
| May 21, 2025 | MGNX MACROGENICS INC | Award(A) Restricted Stock Unit | 3,750 | - | - | Direct |
| May 21, 2025 | MGNX MACROGENICS INC | Award(A) Stock Option (right to buy) | 22,000 | - | - | Direct |
| May 21, 2025 | MGNX MACROGENICS INC | Award(A) Stock Option (right to buy) | 64,961 | $1.27 | - | Direct |
| May 20, 2025 | MGNX MACROGENICS INC | Exercise(M) | 6,500 | - | - | Direct |
1-8 of 8 transactions
About O'Brien Federica F.
O'Brien Federica F. (SEC CIK 0001140119) files insider reports with the SEC as Director of MACROGENICS INC (MGNX) and Director of TELA Bio, Inc. (TELA).
Signal8 holds 3 ownership filings by O'Brien Federica F., all Form 4s, filed between May 22, 2025 and May 20, 2026. Those filings report 8 transactions, from May 20, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on O'Brien Federica F.'s filings is in ROCKVILLE, MD.
Recent filings by O'Brien Federica F.
- May 19, 2026: Grants or awards of MGNX derivative securities (2 lines, Form 4, code A).
- May 18, 2026: Option exercise of MGNX shares (Form 4, code M).
- May 28, 2025: Grant or award of TELA shares (Form 4, code A).
- May 21, 2025: Grants or awards of MGNX derivative securities (3 lines, Form 4, code A).
- May 20, 2025: Option exercise of MGNX shares (Form 4, code M).
Other insiders filing for MACROGENICS INC (MGNX)
- VASCONCELLES MICHAEL, Director
- Kuriakose Emil, Director
- Bonvini Ezio, Sr VP, Research & CSO
- Peters Jeffrey Stuart, Senior VP, GC, and Secretary
- Jackson Scott Thomas, Director
- HEIDEN WILLIAM K, Director